Arcturus Therapeutics Holdings Inc. (ARCT) › Capital ExpendituresArcturus Therapeutics Holdings Inc. (ARCT) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2018: $1.48M2019: $818.0K2020: $1.74M2021: $3.41M2022: $7.73M2023: $2.90M2024: $648.0K2025: $230.0K$230.0K2018Capital Expenditures (USD)2025Fiscal YearCapital ExpendituresChange YoY2025$230.0K-64.5%2024$648.0K-77.7%2023$2.90M-62.5%2022$7.73M+126.8%2021$3.41M+95.5%2020$1.74M+113.0%2019$818.0K-44.7%2018$1.48M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share